Table 2.
Densities of uroguanylin immunoreactive cells in the duodenum of patients with irritable bowel syndrome before and after fecal microbiota transplantation.
| Uroguanylin immunoreactive cells density | |||
|---|---|---|---|
| Before FMT | After FMT | P value | |
| Total IBS group | |||
| Villi (cells/100 epithelial cells) | 44 ± 5.5 | 41 ± 2.3 | 0.5 |
| Crypts (cells/mm2) | 116 ± 8 | 96 ± 3 | 0.049 |
| PI-IBS | |||
| Villi (cells/100 epithelial cells) | 45.8 ± 7.4 | 40.5 ± 3.3 | 0.6 |
| Crypts (cells/mm2) | 108 ± 11.8 | 102.5 ± 4 | 0.6 |
| Idiopathic IBS | |||
| Villi (cells/100 epithelial cells) | 42.5 ± 8.8 | 40.7 ± 3.6 | 0.8 |
| Crypts (cells/mm2) | 124 ± 11 | 89.5 ± 4 | 0.04 |
Comparison: Paired t-test. Data are presented as the mean ± SEM. IBS: irritable bowel syndrome; PI: post infectious.